These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31842910)

  • 21. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.
    Arrieta O; Gallardo-Rincón D; Villarreal-Garza C; Michel RM; Astorga-Ramos AM; Martínez-Barrera L; de la Garza J
    J Thorac Oncol; 2009 Jul; 4(7):845-52. PubMed ID: 19487963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
    Dang J; Li G; Lu X; Yao L; Zhang S; Yu Z
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1169-78. PubMed ID: 20130912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors for survival and correlation to toxicity in advanced Stage III non-small cell lung cancer patients with concurrent chemoradiation.
    Kim YH; Ahn SJ; Kim YC; Kim KS; Oh IJ; Ban HJ; Chung WK; Nam TK; Yoon MS; Jeong JU; Song JY
    Jpn J Clin Oncol; 2016 Feb; 46(2):144-51. PubMed ID: 26590014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
    Tsujino K; Hashimoto T; Shimada T; Yoden E; Fujii O; Ota Y; Satouchi M; Negoro S; Adachi S; Soejima T
    J Thorac Oncol; 2014 Jul; 9(7):983-990. PubMed ID: 24922010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer.
    Kerner GS; van Dullemen LF; Wiegman EM; Widder J; Blokzijl E; Driever EM; van Putten JW; Liesker JJ; Renkema TE; Pieterman RM; Mertens MJ; Hiltermann TJ; Groen HJ
    Radiat Oncol; 2014 Aug; 9():190. PubMed ID: 25174943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
    Ren C; Ji T; Liu T; Dang J; Li G
    Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer.
    Zhang J; Gay HA; Russo S; Parent T; Aljumaily R; Walker PR
    Lung Cancer; 2014 Jan; 83(1):67-72. PubMed ID: 24246506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer.
    Amin NP; Miften M; Thornton D; Ryan N; Kavanagh B; Gaspar LE
    Med Dosim; 2013; 38(3):320-6. PubMed ID: 23611631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of concurrent radiotherapy with weekly docetaxel and platinum-based chemotherapy in stage III non-small-cell lung cancer.
    Kaderbhaï CG; Coudert B; Bertaut A; Adnet J; Favier L; Lagrange A; Peignaux-Casasnovas K; Mettey L; Tharin Z; Foucher P; Martin E
    Cancer Radiother; 2020 Jul; 24(4):279-287. PubMed ID: 32439358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer.
    Divers SG; Spencer SA; Carey D; Busby EM; Hyatt MD; Robert F
    J Clin Oncol; 2005 Sep; 23(27):6664-73. PubMed ID: 16170174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy.
    Chen F; Niu J; Wang M; Zhu H; Guo Z
    Radiat Oncol; 2024 May; 19(1):67. PubMed ID: 38816745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomes.
    Phernambucq EC; Hartemink KJ; Smit EF; Paul MA; Postmus PE; Comans EF; Senan S
    J Thorac Oncol; 2012 Aug; 7(8):1271-5. PubMed ID: 22659960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of radiation pneumonitis and predictive factors in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.
    Gunnarsson K; Mövik L; Pettersson N; Bäck A; Nyman J; Hallqvist A
    Acta Oncol; 2024 Oct; 63():791-797. PubMed ID: 39415565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer.
    Movsas B; Langer CJ; Ross HJ; Wang L; Jotte RM; Feigenberg S; Xu F; Huang CH; Monberg MJ; Obasaju CK
    J Thorac Oncol; 2010 May; 5(5):673-9. PubMed ID: 20354453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between radiation pneumonitis and tumor response in patients with NSCLC treated with chemoradiation.
    MacManus MP; Ball D; Hicks RJ
    Radiat Oncol; 2014 Oct; 9():217. PubMed ID: 25318863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer.
    De Petris L; Lax I; Sirzén F; Friesland S
    Med Oncol; 2005; 22(4):375-81. PubMed ID: 16260855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect analysis of chemoradiotherapy after operation in patients with stage III A non-small cell lung cancer.
    Chen S; Cheng YL; Li ST; Ni YJ; Gu B
    Asian Pac J Trop Med; 2012 Oct; 5(10):823-7. PubMed ID: 23043924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer.
    Amin NP; Miften M; Kavanagh B; Raben D; Camidge DR; Thornton D; Rochford N; Gaspar LE
    J Thorac Oncol; 2011 Sep; 6(9):1553-62. PubMed ID: 21642862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the incidence of ≥ grade 2 radiation pneumonitis between intensity-modulated radiotherapy and three-dimensional conformal radiotherapy in patients with unresectable non-small cell lung cancer treated with durvalumab after concurrent chemoradiotherapy.
    Masuo M; Shinohara E; Kitano M; Maruta R; Chonabayashi S; Endo S; Matumoto S; Nishiyama N; Machitori Y; Kobayashi M
    Jpn J Clin Oncol; 2024 Mar; 54(3):312-318. PubMed ID: 38010609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.